Treatment OutcomeRetrospective StudiesRisk FactorsProspective StudiesFollow-Up StudiesPrognosisTime FactorsRisk AssessmentClinical Trials as TopicUnited StatesSurvival AnalysisPredictive Value of TestsPatient SelectionSensitivity and SpecificityCohort StudiesSurvival RateRandomized Controlled Trials as TopicReproducibility of ResultsSeverity of Illness IndexAge FactorsDrug AgonismNeoplasmsAntineoplastic AgentsDrug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsPrevalenceKidney Failure, ChronicResearch DesignChronic DiseaseIncidenceQuality of LifeCultural DiversityKaplan-Meier EstimatePostoperative ComplicationsDisease-Free SurvivalRenal DialysisDrugs, InvestigationalCritical IllnessRecurrenceDouble-Blind MethodComorbidityOutcome Assessment (Health Care)Disease ProgressionPractice Guidelines as TopicNeoplasm StagingQuestionnairesBiological MarkersCost-Benefit AnalysisPilot ProjectsSafetyBreast NeoplasmsSocial DiscriminationBehavioral SciencesEvidence-Based MedicineCritical CareCombined Modality TherapyTomography, X-Ray ComputedNomogramsCultural CompetencyRegistriesNeoplasm Recurrence, LocalVulnerable PopulationsFeasibility StudiesDose-Response Relationship, DrugMultivariate AnalysisLength of StayChi-Square DistributionAnalysis of VarianceLogistic ModelsOutcome and Process Assessment (Health Care)AlgorithmsArea Under CurveCase-Control StudiesInfusions, IntravenousIntensive Care UnitsPatient PositioningHeart FailureLung NeoplasmsOhioDrug Therapy, CombinationCross-Sectional StudiesPatient ComplianceEndpoint DeterminationMedical RecordsPostal ServiceClinical Trials, Phase II as TopicProsthesis DesignROC CurveAcademic Medical CentersMagnetic Resonance ImagingSex FactorsAnti-Bacterial AgentsReference ValuesAnticoagulantsTurkeyDental Care for DisabledTuberculosis, OcularProportional Hazards ModelsHospitalizationTreatment Failure